# Effect on RLS Symptom Severity After Switching to Neupro® in Patients Who Previously Experienced Augmentation

> **NCT01386944** · — · COMPLETED · sponsor: **UCB Pharma** · enrollment: 102 (actual)

## Conditions studied

- Restless Legs Syndrome

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01386944
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2018-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01386944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01386944, "Effect on RLS Symptom Severity After Switching to Neupro® in Patients Who Previously Experienced Augmentation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01386944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*